Cardiac risk in recovered Covid-19 patients evaluated by 123I-mIBG

Cardiac risk in recovered Covid-19 patients evaluated by 123I-mIBG

Abstract To determine whether cardiac sympathetic nervous dysfunction is present, in this single center prospective, non-randomized trial non-invasive SPECT/CT imaging using the radiotracer 123I-metaiodobenzylguanidine was performed in 33 recovered COVID-19 patients without pre-existing cardiac cond...

Full description

Saved in:
Bibliographic Details
Main Authors: Alessandro Liebich, Gabriel Sheikh, Ralph. A. Bundschuh, Malte Kircher, Alexander Dierks, Bernd Nittbaur, Philip Raake, Maximilian Rieger, Takahiro Higuchi, Christian H. Pfob, Constantin Lapa
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-025-02212-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-02212-7

Similar Items